Skip to main content

Table 5 Kaplan–Meier analysis of the association between MIR17HG variants and OS and PFS of glioma patients

From: Genetic variants in MIR17HG affect the susceptibility and prognosis of glioma in a Chinese Han population

SNP ID Genotype OS PFS
Event/ Total SR (1−/3-year) MST (month) Log-rank p Event/ Total SR (1−/3-year) MST (month) Log-rank p
Overall
 rs17735387 GG 356/395 0.299/0.082 11.0 0.070 355/394 0.157/0.088 8.0 0.026
GA 153/174 0.360/0.101 12.0 150/170 0.216/0.094 8.0
AA 18/23 0.435/− 12.0 18/23 0.304/− 9.0
 rs72640334 CC 433/487 0.319/0.092 11.0 0.365 430/483 0.179/0.092 8.0 0.470
CA 86/96 0.333/0.082 10.0 85/95 0.179/0.093 8.0
AA 7/7 0.143/− 10.0 7/7 0.286/− 8.0
 rs7318578 AA 263/294 0.335/0.085 12.0 0.755 262/293 0.192/0.083 8.0 0.527
AC 160/180 0.306/0.093 11.0 159/178 0.163/0.097 8.0
CC 102/116 0.319/0.111 11.0 101/115 0.176/− 8.0
 rs7336610 TT 129/144 0.326/0.095 11.0 0.740 129/144 0.174/0.096 8.0 0.516
TC 281/314 0.296/0.085 11.0 279/312 0.167/0.089 8.0
CC 116/133 0.381/0.095 12.0 114/130 0.221/0.098 8.0
 rs75267932 AA 425/479 0.323/0.091 11.0 0.766 422/475 0.185/0.092 8.0 0.634
AG 92/103 0.311/0.095 10.0 91/102 0.176/0.097 8.0
GG 10/10 0.400/− 12.0 10/10 0.100/− 8.0
Low-grade glioma (I-II)
 rs17735387 GG 232/260 0.292/0.090 11.0 0.032 232/260 0.158/0.093 8.0 0.013
GA 86/102 0.398/0.149 12.0 84/100 0.255/0.135 9.0
AA 12/16 0.500/− 12.0 12/16 0.375/− 9.0
Females
 rs72640334 CC 196/221 0.335/0.100 12.0 0.035 195/219 0.168/0.094 8.0 0.049
CA 36/39 0.205/− 9.0 35/38 0.105/− 6.0
AA 6/6 0.167/− 10.0 6/6 −/− 8.0
Age ≥ 40 years
 rs17735387 GG 217/232 0.246/0.051 10.0 0.002 216/231 0.134/0.059 8.0 0.002
GA 78/86 0.360/0.081 12.0 78/86 0.178/0.080 8.0
AA 7/11 0.303/− 16.0 7/11 0.545 13.0
  1. Abbreviations: OS Overall survival, PFS Progression free survival, SR Survival rate, MST Median survival time
  2. Log-rank p values were calculated using the Chi-Square test
  3. Bold p < 0.05 indicates statistical significance